Bio-Rad Laboratories Class A
204 hedge funds and large institutions have $2.2B invested in Bio-Rad Laboratories Class A in 2014 Q2 according to their latest regulatory filings, with 33 funds opening new positions, 80 increasing their positions, 57 reducing their positions, and 22 closing their positions.
691% more call options, than puts
Call options by funds: $1.8M | Put options by funds: $227K
50% more first-time investments, than exits
New positions opened: 33 | Existing positions closed: 22
40% more repeat investments, than reductions
Existing positions increased: 80 | Existing positions reduced: 57
6% more funds holding
Funds holding: 193 → 204 (+11)
1.25% more ownership
Funds ownership: 76.44% → 77.69% (+1.2%)
4% less capital invested
Capital invested by funds: $2.31B → $2.2B (-$101M)
50% less funds holding in top 10
Funds holding in top 10: 4 → 2 (-2)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Norges Bank
Oslo,
Norway
|
+$18.9M |
| 2 |
RRAM
River Road Asset Management
Louisville,
Kentucky
|
+$14.2M |
| 3 |
TSW
Thompson Siegel & Walmsley
Richmond,
Virginia
|
+$14M |
| 4 |
NFA
Nationwide Fund Advisors
Columbus,
Ohio
|
+$12.2M |
| 5 |
NIMC
NWQ Investment Management Company
Los Angeles,
California
|
+$11M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
-$24.4M |
| 2 |
TM
Tikvah Management
Charlotte,
North Carolina
|
-$12.2M |
| 3 |
KCM
Kennedy Capital Management
St Louis,
Missouri
|
-$10.9M |
| 4 |
First Trust Advisors
Wheaton,
Illinois
|
-$8.15M |
| 5 |
RA
Royce & Associates
New York
|
-$7.33M |
BIO Hedge Fund Activity: Q2 2014 in Review
204 of the 3,479 institutional investors tracked by Wall St. Rank reported a position in Bio-Rad Laboratories Class A (BIO) for Q2 2014, worth a combined $2.2B — down 4.4% from $2.31B a quarter earlier.
Buyers outnumbered sellers: 33 funds opened new BIO positions and 22 closed out — a net gain of 11 holders — while 80 added to existing stakes and 57 trimmed.
The largest buyer was Norges Bank, adding an estimated $18.9M. The largest seller was Fidelity Investments, cutting an estimated $24.4M.
- 204 institutional investors held Bio-Rad Laboratories Class A (BIO) as of Q2 2014, up from 193 in Q1 2014.
- Funds reported $2.2B of Bio-Rad Laboratories Class A stock for Q2 2014, down 4.4% quarter-over-quarter.
- 33 funds opened new Bio-Rad Laboratories Class A positions in Q2 2014 and 22 closed out, a net change of +11 holders.
- The largest Bio-Rad Laboratories Class A buyer in Q2 2014 was Norges Bank, an estimated $18.9M added.
- The largest Bio-Rad Laboratories Class A seller in Q2 2014 was Fidelity Investments, an estimated $24.4M sold.
Based on aggregated 13F filings for Q2 2014.